Valuation: Proteome Sciences plc

Market Cap 57.87L 76.72L 67.15L 62.01L 1.09Cr 73Cr 1.11Cr 7.44Cr 2.89Cr 36Cr 2.88Cr 2.82Cr 124.74Cr P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 2.08Cr 2.75Cr 2.41Cr 2.23Cr 3.91Cr 260.7Cr 3.98Cr 27Cr 10Cr 128.51Cr 10Cr 10Cr 447.83Cr EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
1 day-8.33%
1 week+10.00%
Current month+17.86%
1 month+17.86%
3 months+2.80%
6 months-26.83%
Current year-34.00%
1 week 1.3
Extreme 1.3
2.3
1 month 1.3
Extreme 1.3
2.3
Current year 1.2
Extreme 1.2
4.4
1 year 1.2
Extreme 1.2
4.4
3 years 1.2
Extreme 1.2
8.71
5 years 1.2
Extreme 1.2
8.79
10 years 1.2
Extreme 1.2
20.25
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 71 01/07/2014
Date Insider Type Main position Quantity % Market Cap.
14/23/14
Vulpes Investment Management Pte Ltd.
BuyCompany 1,00,000 0.0339%
14/23/14
Vulpes Investment Management Pte Ltd.
BuyCompany 1,00,000 0.0339%
06/23/06
Vulpes Investment Management Pte Ltd.
BuyCompany 1,00,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-8.33%+10.00%-45.90%-79.44% 83.64L
-2.12%+3.31%-32.48%-15.72% 16TCr
-3.34%-1.31%-9.06%-9.84% 10TCr
+0.47%+4.31%-5.49%+48.53% 5.48TCr
+0.56%-3.80%+53.05%+53.64% 5.33TCr
-2.49%+7.55%-11.43%-41.91% 4.28TCr
-0.43%+13.63% - - 3.35TCr
-3.76%-2.49%-21.99%-47.36% 2.7TCr
+1.22%+8.88%+64.02%-4.87% 2.51TCr
-1.25%+5.07%-11.82%-4.72% 2.08TCr
Average -1.59%+6.77%-2.34%-11.30% 5.22TCr
Weighted average by Cap. -0.92%+4.65%-6.91%-2.72%

Financials

2024 2025
Net sales 48.87L 64.79L 56.7L 52.37L 91.95L 61Cr 93.62L 6.28Cr 2.44Cr 30Cr 2.43Cr 2.38Cr 105.34Cr 37.56L 49.8L 43.58L 40.25L 70.67L 47Cr 71.95L 4.83Cr 1.87Cr 23Cr 1.87Cr 1.83Cr 81Cr
Net income -34.06L -45.16L -39.52L -36.5L -64.09L -43Cr -65.25L -4.38Cr -1.7Cr -21Cr -1.7Cr -1.66Cr -73Cr -30.61L -40.58L -35.52L -32.8L -57.6L -38Cr -58.64L -3.94Cr -1.53Cr -19Cr -1.52Cr -1.49Cr -66Cr
Net Debt 1.34Cr 1.78Cr 1.55Cr 1.44Cr 2.52Cr 168.07Cr 2.57Cr 17Cr 6.68Cr 83Cr 6.67Cr 6.52Cr 288.71Cr 1.5Cr 1.99Cr 1.74Cr 1.61Cr 2.82Cr 188.08Cr 2.87Cr 19Cr 7.47Cr 93Cr 7.46Cr 7.3Cr 323.09Cr
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
30/26/30 GBX 1.650 -8.33% 54,141
29/26/29 GBX 1.800 +4.96% 4,86,345
26/26/26 GBX 1.715 +1.48% 6,875
25/26/25 GBX 1.690 +11.92% 64,047
24/26/24 GBX 1.510 +0.67% 2,60,425